The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptorMechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factorExperimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of ActionEpigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironmentConstructing molecular classifiers for the accurate prognosis of lung adenocarcinomaConfirmation of gene expression-based prediction of survival in non-small cell lung cancerPredicting cancer drug response by protoeomic profilingPopulation-based molecular prognosis of breast cancer by transcriptional profilingPrognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewDeficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell deathControlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cellsIntracellular association of a mutant insulin-like growth factor receptor with endogenous receptorsSelective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cellsUpregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicityATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemiaImportance of EGFR/ERCC1 interaction following radiation-induced DNA damageBortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathwayBortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosisImpairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complexMembranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitroA homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinomaClass I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivoS100P promotes pancreatic cancer growth, survival, and invasionEnhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinomaShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growthBrachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancerHigh expression of methionine aminopeptidase 2 in human colorectal adenocarcinomasStructural and functional alterations of FLT3 in acute myeloid leukemiaPhase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerIncreased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokersDurable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapyImmune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Lung cancer in never smokers: clinical epidemiology and environmental risk factorsSpecific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsAfliberceptIL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcomaPharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein bindingNew strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathwayVascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserineHistone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma
P1433
Q22008005-9A6D0066-0F3B-4E02-A149-493BBC61C071Q22008006-D07BE9B8-5879-4F9D-B9E6-45BDF91A0D7BQ22061792-B3B5BE5F-1245-4FC8-8D9C-8A06BE52B980Q22253236-B5959778-C468-4DBF-BBB1-54A6F04D2B92Q23916642-7179221F-3C01-479B-A901-22404E6C8271Q23918759-B02E6823-BE8E-4ACB-A2C0-CCFAA097A537Q23924005-0D2191A9-ADA8-4E73-B143-84DE3798D3BEQ23924006-D843CB4F-9FD4-434B-B58B-37BC5CF8B66EQ24289005-FDC70463-19CC-4F94-A545-7D98D890B31AQ24291223-8A6D4C4C-93CD-4039-B57F-7B5CB905F19DQ24291437-7051AAF3-2EC9-4FA3-B7BE-89BE6EB53A55Q24291438-86CBC4B7-6B46-428A-8AA2-76C67B184484Q24291537-84582623-C7BA-4E00-85C5-A687DDEF190FQ24292793-0409630F-67E8-4B8A-9035-A20A015BBC83Q24294138-B5301406-5AD6-410F-8858-6B1F95087AD9Q24296387-B9498860-AA3A-4B26-ACAF-412E2F270762Q24298796-418AB61F-88DC-4DAC-B3E5-15320F95FBE8Q24300558-E1CFD15B-2E60-4E57-9B58-E5AD65E81CC3Q24306474-A6D672B2-74A2-491D-8061-1FFE447579DAQ24307058-952602B8-BACC-4E26-A407-59C631FA9167Q24309089-BFC2DE77-7B26-479B-B0C8-5D38917CDE0CQ24312156-34DE039A-BE47-45F3-8AB8-5E46822B027FQ24312176-6161F15E-8EDA-4C98-B2BD-BFAF83C10FD6Q24318891-24FED2A3-861A-47BE-BCA7-1BF013D8F4FDQ24322609-6CFCF2D7-4F3E-4DA5-BFE0-2FD2B899A1E5Q24324198-463A480C-4163-451C-98A5-5F97891E1D73Q24337546-695ECD21-C713-4B9D-8E8B-8DF866C5D268Q24338964-88BDC238-9C56-4AAD-AB48-A6F2D0C29227Q24563045-E9ACE813-7D7E-4BA7-A4A8-453DCCD76863Q24595630-41F6A0DB-A965-4197-B3F3-4C046EE6A933Q24596055-9857211A-A3F6-41E3-8BE1-5F62CED94675Q24596171-F324442E-90A8-46EE-9C1A-547411924C3FQ24598433-46521BCB-30D8-457D-9F91-0AEF621BF9C9Q24598792-FD9EBCE5-A3D8-41A8-91E0-45DADC594C8BQ24600199-0FAE469A-B496-4CA3-9C3A-5E4F3F539E6FQ24601302-5A103969-82D6-498F-A479-7EFC8C4C694EQ24602935-9E0F21E3-FD45-463D-9945-CA17CFC4D534Q24603649-6F82E518-3123-44C3-900A-B1CF2F8C9F5FQ24605725-B2506AC5-1E1A-464A-BD95-3CC705326949Q24606279-AD27ECE9-3272-44BF-AED9-1A78E321867C
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista
@es
revue scientifique
@fr
vědecký časopis
@cs
wetenschappelijk tijdschrift van American Association for Cancer Research
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Clinical Cancer Research
@ast
Clinical Cancer Research
@da
Clinical Cancer Research
@de
Clinical Cancer Research
@en
Clinical Cancer Research
@es
Clinical Cancer Research
@fi
Clinical Cancer Research
@fr
Clinical Cancer Research
@it
Clinical Cancer Research
@nb
Clinical Cancer Research
@nl
type
label
Clinical Cancer Research
@ast
Clinical Cancer Research
@da
Clinical Cancer Research
@de
Clinical Cancer Research
@en
Clinical Cancer Research
@es
Clinical Cancer Research
@fi
Clinical Cancer Research
@fr
Clinical Cancer Research
@it
Clinical Cancer Research
@nb
Clinical Cancer Research
@nl
prefLabel
Clinical Cancer Research
@ast
Clinical Cancer Research
@da
Clinical Cancer Research
@de
Clinical Cancer Research
@en
Clinical Cancer Research
@es
Clinical Cancer Research
@fi
Clinical Cancer Research
@fr
Clinical Cancer Research
@it
Clinical Cancer Research
@nb
Clinical Cancer Research
@nl
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Clin. Cancer Res.
P1277
P1476
Clinical Cancer Research
@en
P236
P243
P407
P571
1995-01-01T00:00:00Z